Sumitomo Life Insurance Co. bought a new stake in Corteva, Inc. (NYSE:CTVA – Free Report) during the second quarter, Holdings Channel reports. The institutional investor bought 26,800 shares of the company’s stock, valued at approximately $2,269,000.
Other large investors have also recently bought and sold shares of the company. Brighton Jones LLC grew its position in Corteva by 307.2% during the 4th quarter. Brighton Jones LLC now owns 15,588 shares of the company’s stock worth $888,000 after purchasing an additional 11,760 shares during the last quarter. Woodline Partners LP raised its holdings in shares of Corteva by 40.3% in the first quarter. Woodline Partners LP now owns 57,919 shares of the company’s stock valued at $3,645,000 after buying an additional 16,644 shares during the last quarter. EverSource Wealth Advisors LLC raised its holdings in shares of Corteva by 62.1% in the second quarter. EverSource Wealth Advisors LLC now owns 2,559 shares of the company’s stock valued at $191,000 after buying an additional 980 shares during the last quarter. Cresset Asset Management LLC boosted its stake in shares of Corteva by 2.6% during the second quarter. Cresset Asset Management LLC now owns 7,063 shares of the company’s stock worth $526,000 after buying an additional 181 shares during the period. Finally, Jump Financial LLC purchased a new position in shares of Corteva during the second quarter worth about $1,464,000. Institutional investors and hedge funds own 81.54% of the company’s stock.
Wall Street Analysts Forecast Growth
Several research firms have commented on CTVA. Weiss Ratings downgraded Corteva from a “hold (c+)” rating to a “hold (c)” rating in a research note on Monday, August 3rd. Morgan Stanley boosted their target price on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a report on Thursday, May 28th. Bank of America upped their price target on Corteva from $90.00 to $96.00 and gave the stock a “buy” rating in a research note on Monday, July 20th. Barclays increased their price target on Corteva from $84.00 to $91.00 and gave the stock an “overweight” rating in a report on Thursday, June 11th. Finally, JPMorgan Chase & Co. boosted their price objective on shares of Corteva from $77.00 to $83.00 and gave the company a “neutral” rating in a research note on Monday, August 3rd. Fourteen analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average target price of $91.50.
Corteva Stock Performance
NYSE:CTVA opened at $81.84 on Friday. The firm’s fifty day simple moving average is $82.13 and its 200-day simple moving average is $80.21. The company has a quick ratio of 1.10, a current ratio of 1.52 and a debt-to-equity ratio of 0.07. The stock has a market cap of $54.60 billion, a PE ratio of 54.20, a price-to-earnings-growth ratio of 2.44 and a beta of 0.57. Corteva, Inc. has a fifty-two week low of $60.53 and a fifty-two week high of $90.97.
Corteva (NYSE:CTVA – Get Free Report) last announced its quarterly earnings data on Thursday, July 30th. The company reported $2.30 EPS for the quarter, beating the consensus estimate of $2.24 by $0.06. The firm had revenue of $6.38 billion during the quarter, compared to analysts’ expectations of $6.60 billion. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The business’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter last year, the business earned $2.20 earnings per share. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. Analysts expect that Corteva, Inc. will post 3.72 earnings per share for the current fiscal year.
Corteva Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Tuesday, September 15th. Stockholders of record on Tuesday, September 1st will be given a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Tuesday, September 1st. Corteva’s dividend payout ratio (DPR) is presently 47.68%.
Corteva Company Profile
Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.
Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.
Read More
- Five stocks we like better than Corteva
- Blueprint for a Boom: SEC Clears the Crypto Runway
- Ross Stores Just Flipped the Off-Price Retail Story After TJX’s Marmaxx Miss
- Advance Auto Parts Plunged, But Its Turnaround Is Still Working
- Is Palo Alto Networks Priced for Perfection Again as AI Security Demand Accelerates?
Want to see what other hedge funds are holding CTVA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Corteva, Inc. (NYSE:CTVA – Free Report).
Receive News & Ratings for Corteva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corteva and related companies with MarketBeat.com's FREE daily email newsletter.
